A Phase I, Open-label, Dosimetry, Biodistribution and Pharmacokinetic Study of Alpharadin™ in Patients With Hormone Refractory Prostate Cancer and Skeletal ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2007-2008

ABSTRACT

Primary objective: To investigate the biodistribution, radiation dosimetry, and pharmacokinetics of two separate intravenous (IV) injections of Xofigo (100 kBq/kg body weight [b.w.] [=110 kBq/kg based on the 2015 National Institute of Standards and Technology standardization], 6 weeks apart). Secondary objectives: To determine the safety of IV injections of Xofigo after two separate injections (6 weeks apart), to evaluate treatment response (antitumour effect in osteoblastic bone metastases) of Xofigo treatment consisting of two injections of activity 100 kBq/kg b.w. (=110 kBq/kg based on the 2015 National Institute of Standards and Technology standardization), 6 weeks apart and to evaluate long term radiation toxicity and to collect survival data at 6 and 12 months after the first injection More... »

URL

https://clinicaltrials.gov/show/NCT00667537

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "Primary objective: To investigate the biodistribution, radiation dosimetry, and pharmacokinetics of two separate intravenous (IV) injections of Xofigo (100 kBq/kg body weight [b.w.] [=110 kBq/kg based on the 2015 National Institute of Standards and Technology standardization], 6 weeks apart). Secondary objectives: To determine the safety of IV injections of Xofigo after two separate injections (6 weeks apart), to evaluate treatment response (antitumour effect in osteoblastic bone metastases) of Xofigo treatment consisting of two injections of activity 100 kBq/kg b.w. (=110 kBq/kg based on the 2015 National Institute of Standards and Technology standardization), 6 weeks apart and to evaluate long term radiation toxicity and to collect survival data at 6 and 12 months after the first injection", 
    "endDate": "2008-12-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT00667537", 
    "keywords": [
      "label", 
      "dosimetry", 
      "biodistribution", 
      "pharmacokinetic study", 
      "hormone-refractory prostate cancer", 
      "skeletal metastasis", 
      "primary objective", 
      "Radiometry", 
      "pharmacokinetics", 
      "injection", 
      "body weight", 
      "National Institute", 
      "technology", 
      "secondary objective", 
      "safety", 
      "treatment response", 
      "bone metastasis", 
      "National Institute of Standards", 
      "radiation toxicity", 
      "survival data"
    ], 
    "name": "A Phase I, Open-label, Dosimetry, Biodistribution and Pharmacokinetic Study of Alpharadin\u2122 in Patients With Hormone Refractory Prostate Cancer and Skeletal Metastases", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT00667537"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00005.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.419670.d", 
        "type": "Organization"
      }
    ], 
    "startDate": "2007-07-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "https://doi.org/10.1097/mnm.0b013e328353bb6e", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007036589"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2967/jnumed.115.157123", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032943107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/2191-219x-1-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035541884", 
          "https://doi.org/10.1186/2191-219x-1-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1088/0031-9155/57/10/3207", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059029204"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT00667537"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT00667537'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT00667537'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT00667537'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT00667537'


 

This table displays all metadata directly associated to this object as RDF triples.

52 TRIPLES      16 PREDICATES      39 URIs      29 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT00667537 schema:about anzsrc-for:3053
2 schema:description Primary objective: To investigate the biodistribution, radiation dosimetry, and pharmacokinetics of two separate intravenous (IV) injections of Xofigo (100 kBq/kg body weight [b.w.] [=110 kBq/kg based on the 2015 National Institute of Standards and Technology standardization], 6 weeks apart). Secondary objectives: To determine the safety of IV injections of Xofigo after two separate injections (6 weeks apart), to evaluate treatment response (antitumour effect in osteoblastic bone metastases) of Xofigo treatment consisting of two injections of activity 100 kBq/kg b.w. (=110 kBq/kg based on the 2015 National Institute of Standards and Technology standardization), 6 weeks apart and to evaluate long term radiation toxicity and to collect survival data at 6 and 12 months after the first injection
3 schema:endDate 2008-12-01T00:00:00Z
4 schema:keywords National Institute
5 National Institute of Standards
6 Radiometry
7 biodistribution
8 body weight
9 bone metastasis
10 dosimetry
11 hormone-refractory prostate cancer
12 injection
13 label
14 pharmacokinetic study
15 pharmacokinetics
16 primary objective
17 radiation toxicity
18 safety
19 secondary objective
20 skeletal metastasis
21 survival data
22 technology
23 treatment response
24 schema:name A Phase I, Open-label, Dosimetry, Biodistribution and Pharmacokinetic Study of Alpharadin™ in Patients With Hormone Refractory Prostate Cancer and Skeletal Metastases
25 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT00667537
26 schema:sdDatePublished 2019-03-07T15:23
27 schema:sdLicense https://scigraph.springernature.com/explorer/license/
28 schema:sdPublisher Nc831cf3de82242048f2b5509439a6fb3
29 schema:sponsor https://www.grid.ac/institutes/grid.419670.d
30 schema:startDate 2007-07-01T00:00:00Z
31 schema:subjectOf sg:pub.10.1186/2191-219x-1-4
32 https://doi.org/10.1088/0031-9155/57/10/3207
33 https://doi.org/10.1097/mnm.0b013e328353bb6e
34 https://doi.org/10.2967/jnumed.115.157123
35 schema:url https://clinicaltrials.gov/show/NCT00667537
36 sgo:license sg:explorer/license/
37 sgo:sdDataset clinical_trials
38 rdf:type schema:MedicalStudy
39 Nc831cf3de82242048f2b5509439a6fb3 schema:name Springer Nature - SN SciGraph project
40 rdf:type schema:Organization
41 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
42 rdf:type schema:DefinedTerm
43 sg:pub.10.1186/2191-219x-1-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035541884
44 https://doi.org/10.1186/2191-219x-1-4
45 rdf:type schema:CreativeWork
46 https://doi.org/10.1088/0031-9155/57/10/3207 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059029204
47 rdf:type schema:CreativeWork
48 https://doi.org/10.1097/mnm.0b013e328353bb6e schema:sameAs https://app.dimensions.ai/details/publication/pub.1007036589
49 rdf:type schema:CreativeWork
50 https://doi.org/10.2967/jnumed.115.157123 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032943107
51 rdf:type schema:CreativeWork
52 https://www.grid.ac/institutes/grid.419670.d schema:Organization
 




Preview window. Press ESC to close (or click here)


...